Literature DB >> 11689078

Phenoxypropoxybiguanides, prodrugs of DHFR-inhibiting diaminotriazine antimalarials.

N P Jensen1, A L Ager, R A Bliss, C J Canfield, B M Kotecka, K H Rieckmann, J Terpinski, D P Jacobus.   

Abstract

A total of 34 analogues of the biguanide PS-15 (5s), a prodrug of the diaminotriazine WR-99210 (8s), have been prepared. Several of them, such as 5b (PS-33) and 5m (PS-26), maintain or exceed the in vivo activity of PS-15 while not requiring the use of highly regulated starting materials. The putative diaminotriazine metabolites of these new analogues (compounds 8) have also been prepared and shown to maintain the activity against resistant P. falciparum strains. The structure-activity relationships of biguanides 5 and putative metabolites 8 are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689078     DOI: 10.1021/jm010089z

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

1.  Enhanced in vitro activity of dihydrofolate reductase and dihydropteroase synthase inhibitors in combination against Nocardia spp.

Authors:  Deborah M Thielking; Michelle S Destefano; Michael H Cynamon; Anthony E T Yeo
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

Review 2.  Chemotherapeutic hope on the horizon for Plasmodium vivax malaria?

Authors:  Robert G Ridley
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

3.  Regioisomerization of Antimalarial Drug WR99210 Explains the Inactivity of a Commercial Stock.

Authors:  T Parks Remcho; Sravanthi D Guggilapu; Phillip Cruz; Glenn A Nardone; Gavin Heffernan; Robert D O'Connor; Carole A Bewley; Thomas E Wellems; Kristin D Lane
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

Review 4.  Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy.

Authors:  Alexis Nzila; Steve A Ward; Kevin Marsh; Paul F G Sims; John E Hyde
Journal:  Trends Parasitol       Date:  2005-06

5.  Novel Saccharomyces cerevisiae screen identifies WR99210 analogues that inhibit Mycobacterium tuberculosis dihydrofolate reductase.

Authors:  A'Lissa B Gerum; Jonathan E Ulmer; David P Jacobus; Norman P Jensen; David R Sherman; Carol Hopkins Sibley
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

6.  Selective killing of the human malaria parasite Plasmodium falciparum by a benzylthiazolium dye.

Authors:  Jane X Kelly; Rolf W Winter; Theodore P Braun; Myralyn Osei-Agyemang; David J Hinrichs; Michael K Riscoe
Journal:  Exp Parasitol       Date:  2006-12-21       Impact factor: 2.011

Review 7.  Targeting purine and pyrimidine metabolism in human apicomplexan parasites.

Authors:  John E Hyde
Journal:  Curr Drug Targets       Date:  2007-01       Impact factor: 3.465

Review 8.  Modern malaria chemoprophylaxis.

Authors:  G Dennis Shanks; Michael D Edstein
Journal:  Drugs       Date:  2005       Impact factor: 9.546

9.  Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase.

Authors:  Bharath Srinivasan; Sam Tonddast-Navaei; Jeffrey Skolnick
Journal:  Eur J Med Chem       Date:  2015-09-05       Impact factor: 6.514

10.  Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax.

Authors:  Michele D Hastings; Carol Hopkins Sibley
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.